13

rezultāts(-i)

Vārds(-i)
Publikācijas veids
Politikas joma
Jautājuma autors
Datums

What if we could fight drug addiction with digital technology?

12-04-2019

What if digital technology could assist drug addiction recovery by online counselling, monitoring behaviour, and real-time interventions in patients’ everyday lives? Assistance at a distance: how could clinicians, health personnel, friends and family support a patient suffering from drug addiction via digital technology?

What if digital technology could assist drug addiction recovery by online counselling, monitoring behaviour, and real-time interventions in patients’ everyday lives? Assistance at a distance: how could clinicians, health personnel, friends and family support a patient suffering from drug addiction via digital technology?

Technological innovation strategies in substance use disorders

30-03-2017

Drug disorders are complex social and health problems that affect millions of people in the EU. In the last two decades, we have witnessed an extraordinary growth in computer and mobile technologies available to the general public. Researchers in the field of drug addiction have started to exploit the growth of the internet and new technologies, and an increasing number of interventions designed to promote changes in substance use disorders are now available. The study includes an extensive critical ...

Drug disorders are complex social and health problems that affect millions of people in the EU. In the last two decades, we have witnessed an extraordinary growth in computer and mobile technologies available to the general public. Researchers in the field of drug addiction have started to exploit the growth of the internet and new technologies, and an increasing number of interventions designed to promote changes in substance use disorders are now available. The study includes an extensive critical literature review on the potential of new technologies for drug addiction management. A survey among European experts in the field of addiction was also carried out. New technologies have the potential to provide parallel/alternative instruments of information, prevention and treatment for substance use disorders. They have the capacity to reach populations that have not traditionally been in treatment. Despite encouraging progress, new technologies need to be evaluated with caution. Across research studies, there are methodological difficulties, such as a lack of common definitions, selection biases and inappropriate research designs, which require further investigation. To date, new technologies have the potential to affect, and perhaps deeply transform, existing models of health care delivery in the field of addiction.

Ārējais autors

Giovanni Esposito, European Brain Council (EBC): Chapter 6 (drawing up of the questionnaire, gathering of responses, analyse of the results and writing the report).

Human rights in the Philippines

17-01-2017

Since mid-2016, President Rodrigo Duterte's controversial war on drugs has triggered a wave of extrajudicial killings. The current violence reflects longer-term problems, such as high crime rates and a dysfunctional justice system. However, there are still many areas, such as freedom of expression and gender equality, where the Philippines does better than most other Asian countries.

Since mid-2016, President Rodrigo Duterte's controversial war on drugs has triggered a wave of extrajudicial killings. The current violence reflects longer-term problems, such as high crime rates and a dysfunctional justice system. However, there are still many areas, such as freedom of expression and gender equality, where the Philippines does better than most other Asian countries.

A Review and Assessment of EU Drug Policy

28-11-2016

This study, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of the LIBE Committee, provides an overview of the drug policies in international fora, at EU level, in seven Member States and in three non-EU countries. The study highlights the very different approaches taken and their varying level of effectiveness.

This study, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of the LIBE Committee, provides an overview of the drug policies in international fora, at EU level, in seven Member States and in three non-EU countries. The study highlights the very different approaches taken and their varying level of effectiveness.

Ārējais autors

Mirja GUTHEIL, Quentin LIGER, Aurelie HEETMAN, James EAGER and Solveig BOURGEON (Optimity Advisors)

Public Health in the EU: State-of-Play and Key Policy Challenges for the Hearings of Commissioner-Designates, Brussels, 24 & 25 September 2014

15-10-2014

Citizen’s health is a core value of the EU (Art.168, TFEU). While EU public health policy complements national policies, it encourages cooperation across countries and facilitates coordination. Particularly, EU public health policy generates economies of scale by pooling resources to tackle common challenges, such as pandemics or the risk factors associated with chronic diseases. The EU brings added value in fostering research and improving health outcomes through frameworks such as Horizon2020 and ...

Citizen’s health is a core value of the EU (Art.168, TFEU). While EU public health policy complements national policies, it encourages cooperation across countries and facilitates coordination. Particularly, EU public health policy generates economies of scale by pooling resources to tackle common challenges, such as pandemics or the risk factors associated with chronic diseases. The EU brings added value in fostering research and improving health outcomes through frameworks such as Horizon2020 and the third multi-annual Health Programme. This document was provided by Policy Department A in view of the Hearings of Commissioner-Designates of the Environment, Public Health and Food Safety Committee (ENVI).

Ārējais autors

Yoline KUIPERS CAVACO (Milieu Ltd) and Vinciane QUOIDBACH (Elleze)

Afghan opium production reaches record high

15-01-2014

Afghan opium production increased 49% in 2013, reaching a record high. According to the UN Office on Drugs and Crime (UNODC), potential production was even higher, limited only by unfavourable weather conditions, while eradication efforts diminished. The drug trade helps sustain the military conflict and, with presidential elections in 2014 as well as the planned draw-down of foreign troops, it could contribute to an escalation in coming years.

Afghan opium production increased 49% in 2013, reaching a record high. According to the UN Office on Drugs and Crime (UNODC), potential production was even higher, limited only by unfavourable weather conditions, while eradication efforts diminished. The drug trade helps sustain the military conflict and, with presidential elections in 2014 as well as the planned draw-down of foreign troops, it could contribute to an escalation in coming years.

New Psychoactive Substances: Initial Appraisal of the Commission's Impact Assessment

15-01-2014

This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposed changes to the Council Decision on the definition of drugs and a proposed new Regulation on emerging psychoactive substances, submitted on 17 September 2013. It analyses whether the principal criteria laid down in the Commission’s own Impact Assessment Guidelines, as well as additional factors identified by the Parliament in its Impact Assessment ...

This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposed changes to the Council Decision on the definition of drugs and a proposed new Regulation on emerging psychoactive substances, submitted on 17 September 2013. It analyses whether the principal criteria laid down in the Commission’s own Impact Assessment Guidelines, as well as additional factors identified by the Parliament in its Impact Assessment Handbook, appear to be met by the IA. It does not attempt to deal with the substance of the proposal. It is drafted for informational and background purposes to assist the relevant parliamentary committee and Members more widely in their work.

Europe and Latin America : Combating Drugs and Drug Trafficking

22-03-2012

Two decades of cooperation between Europe and Latin America to combat drugs and drug trafficking have had a limited impact in terms of reducing drug consumption and production and have not led to better control of the criminal networks involved in the trafficking. Given this lack of decisive progress, fresh debate is emerging in Latin America on possible alternatives to the traditional models for tackling drugs, which are often seen as increasingly obsolete. These alternatives include measures such ...

Two decades of cooperation between Europe and Latin America to combat drugs and drug trafficking have had a limited impact in terms of reducing drug consumption and production and have not led to better control of the criminal networks involved in the trafficking. Given this lack of decisive progress, fresh debate is emerging in Latin America on possible alternatives to the traditional models for tackling drugs, which are often seen as increasingly obsolete. These alternatives include measures such as decriminalisation and partial regulation of the drugs market. This study contains recent data on illegal drug consumption and production in the EU and Latin America, a general overview of the policies adopted in both regions, and analysis of the main bi-regional cooperation tools and main aspects of the current debate on drug trafficking. The study concludes with a number of recommendations on how to reform the current drugs and drug trafficking strategies and programmes pursued by both regions and with other partners.

Ārējais autors

Susanne Gratius with support from David Palacios (Foundation for International Relations and Dialogue, FRIDE)

The European Union and illicit drugs

03-01-2012

The EU has a central place on the world's map of illegal drug consumption and production. Whereas the use of ""established"" drugs has stabilised in the EU, drug control authorities have increasingly been struggling with the emergence of new psychoactive substances which reproduce the effects of illegal drugs. The UN has created an international system defining drugs of which the production and sale are prohibited. All EU Member States (MS) are parties to the relevant UN conventions. In the EU, drug ...

The EU has a central place on the world's map of illegal drug consumption and production. Whereas the use of ""established"" drugs has stabilised in the EU, drug control authorities have increasingly been struggling with the emergence of new psychoactive substances which reproduce the effects of illegal drugs. The UN has created an international system defining drugs of which the production and sale are prohibited. All EU Member States (MS) are parties to the relevant UN conventions. In the EU, drug policy remains a domain essentially reserved to national policies. However, the EU has been increasingly active with respect to both law enforcement and health-related issues. A new EU joint drug strategy will be adopted in 2012. The European Parliament was the first institution to address illicit drugs at EU level. It has however presented only limited sets of recommendations due to radical differences of opinion amongst MEPs. A 2004 resolution following the report by Giusto Catania, which critically assessed the EU joint strategy, seems not to have had an impact on the overall EU approach to drugs. Whereas MS have willingly cooperated in combating drug trafficking, that has not been the case for regulating drug use, which is addressed in contrasting ways throughout the EU. The Netherlands and Sweden represent the most liberal and the most restrictive ends of the political spectrum.

Doping in Professional Sport

26-06-2008

This study examines the current and future ways in which doping can be detected by reviewing the various practices and sporting disciplines. Going beyond a simple description, the study takes a wider look at the reasons behind the fight against doping, illustrating models which vary in how they address this important issue. Suggestions are also made on how the EU should tackle doping in future, based on the various models described.

This study examines the current and future ways in which doping can be detected by reviewing the various practices and sporting disciplines. Going beyond a simple description, the study takes a wider look at the reasons behind the fight against doping, illustrating models which vary in how they address this important issue. Suggestions are also made on how the EU should tackle doping in future, based on the various models described.

Ārējais autors

Christophe Brissonneau, CERSES UMR 8137 CNRS, Université Paris Descartes.

Gaidāmie notikumi

01-12-2020
FISC Public Hearing on 1st December 2020
Uzklausīšana -
FISC
01-12-2020
Inter-parliamentary Committee meeting on the Evaluation of Eurojust Activities
Cits pasākums -
LIBE
02-12-2020
Public Hearing on AI and Health
Uzklausīšana -
AIDA

Partneri